Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors

References

• Addressing the crisis in antibiotic development. Accessed in January 2022. Available from: https://www.who.int/news/item/09-07-2020-addressing-the-crisis-in-antibiotic-development.
   Google Scholar
• Pulingam T, Parumasivam T, Gazzali AM, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci 2022;170:106103. https://linkinghub.elsevier.com/retrieve/pii/S0928098721004048.
   PubMed Web of Science ®Google Scholar
• Baghdadi JD, Coffey KC, Adediran T, et al. Antibiotic use and bacterial infection among inpatients in the first wave of COVID-19: a Retrospective Cohort Study of 64,691 patients. Antimicrob Agents Chemother 2021;65:PMC8522758.
   PubMed Web of Science ®Google Scholar
• Rizvi SG, Ahammad SZ. COVID-19 and antimicrobial resistance: a cross-study. Sci Total Environ 2022;807:150873.
   PubMed Web of Science ®Google Scholar
• Lobie TA, Roba AA, Booth JA, et al. Antimicrobial resistance: a challenge awaiting the post-COVID-19 era. Int J Infect Dis 2021;111:322–5. https://pubmed.ncbi.nlm.nih.gov/34508864/.
   PubMed Web of Science ®Google Scholar
• Shafran N, Shafran I, Ben-Zvi H, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep 2021;11:1–8. https://www.nature.com/articles/s41598-021-92220-0.
   PubMed Web of Science ®Google Scholar
• Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in Coronavirus Disease 2019. Trends Microbiol 2021;29:930–41.
   PubMed Web of Science ®Google Scholar
• Segrelles-Calvo G, de S Araújo GR, Llopis-Pastor E, et al. Candida spp. co-infection in COVID-19 patients with severe pneumonia: prevalence study and associated risk factors. Respir Med 202;188:106619. http://www.resmedjournal.com/article/S0954611121003279/fulltext.
   Google Scholar
• Moser D, Biere K, Han B, et al. COVID-19 impairs immune response to Candida albicans. Front Immunol 2021;12:250.
   Web of Science ®Google Scholar
• Khurana A, Sardana K, Chowdhary A. Antifungal resistance in dermatophytes: recent trends and therapeutic implications. Fungal Genet Biol 2019;132:103255.
   PubMed Web of Science ®Google Scholar
• Sacheli R, Hayette M-P, Rodrigues CF, et al. Antifungal resistance in dermatophytes: genetic considerations, clinical presentations and alternative therapies. J Fungi 2021;7:983. https://www.mdpi.com/2309-608X/7/11/983/html.
   Web of Science ®Google Scholar
• Patrick MT, Zhang H, Wasikowski R, et al. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. J Allergy Clin Immunol 2021;147:857–69.e7.
   PubMed Web of Science ®Google Scholar
• New Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products. Accessed in January 2022. Available from: https://www.fda.gov/drugs/development-approval-process-drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products.
   Google Scholar
• Analysis Shows Continued Deficiencies in Antibiotic Development since 2014 | The Pew Charitable Trusts. Accessed in January 2022. Available from: https://www.pewtrusts.org/en/research-and-analysis/data-visualizations/2019/five-year-analysis-shows-continued-deficiencies-in-antibiotic-development.
   Google Scholar
• Which pathogens are receiving most attention in R&D? – Access to Medicine Foundation. Accessed in January 2022. Available from: https://accesstomedicinefoundation.org/amr-benchmark/results/which-pathogens-are-receiving-most-attention-in-r-d.
   Google Scholar
• Campestre C, De Luca V, Carradori S, et al. Carbonic anhydrases: new perspectives on protein functional role and inhibition in Helicobacter pylori. Front Microbiol 2021;12:551.
   Web of Science ®Google Scholar
• Supuran CT, Capasso C. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature. Expert Opin Ther Pat 2020;30:963–82..
   PubMed Web of Science ®Google Scholar
• Supuran CT, Capasso C. An overview of the bacterial carbonic anhydrases. Metabolites 2017;7:56. https://www.mdpi.com/2218-1989/7/4/56/htm.
   PubMed Web of Science ®Google Scholar
• Flaherty DP, Seleem MN, Supuran CT. Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. Future Med Chem 2021;13:1619–22. 10.4155/fmc-2021-0207.
   PubMed Web of Science ®Google Scholar
• Grande R, Carradori S, Puca V, et al. Selective inhibition of helicobacter pylori carbonic anhydrases by Carvacrol and thymol could impair biofilm production and the release of outer membrane vesicles. Int J Mol Sci 2021;22:11583. Available from: https://www.mdpi.com/1422-0067/22/21/11583.
   PubMed Web of Science ®Google Scholar
• Güzel-Akdemir Ö, Carradori S, Grande R, et al. Development of thiazolidinones as fungal carbonic anhydrase inhibitors. Int J Mol Sci 2020;21:2960. https://www.mdpi.com/1422-0067/21/8/2960/htm.
   PubMed Web of Science ®Google Scholar
• Cottier F, Leewattanapasuk W, Kemp LR, et al. Carbonic anhydrase regulation and CO(2) sensing in the fungal pathogen Candida glabrata involves a novel Rca1p ortholog. Bioorg Med Chem 2013;21:1549–54.
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin Ther Targets 2015;19:1689–704. https://pubmed.ncbi.nlm.nih.gov/26235676/.
   PubMed Web of Science ®Google Scholar
• Hewitt CS, Abutaleb NS, Elhassanny AEM, et al. Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against neisseria gonorrhoeae. ACS Infect Dis 2021;7:1969–84. 10.1021/acsinfecdis.1c00055.
   PubMed Web of Science ®Google Scholar
• Abutaleb NS, Elkashif A, Flaherty DP, et al. In vivo antibacterial activity of acetazolamide. Antimicrob Agents Chemother 2021;65:e01715–20. https://pubmed.ncbi.nlm.nih.gov/33495225/.
   PubMed Web of Science ®Google Scholar
• Kaur J, Cao X, Abutaleb NS, et al. Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant enterococcus. J Med Chem 2020;63:9540–62. https://pubmed.ncbi.nlm.nih.gov/32787141/.
   PubMed Web of Science ®Google Scholar
• Abutaleb NS, Elhassanny AEM, Flaherty DP, et al. In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. PeerJ 2021;9:e11059. https://pubmed.ncbi.nlm.nih.gov/33850651/.
   PubMed Web of Science ®Google Scholar
• Urbanski LJ, Bua S, Angeli A, et al. Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase. J Enzyme Inhib Med Chem 2020;35:1834–9.
   PubMed Web of Science ®Google Scholar
• Urbanski LJ, Vullo D, Parkkila S, et al. An anion and small molecule inhibition study of the β-carbonic anhydrase from Staphylococcus aureus. J Enzyme Inhib Med Chem 2021;36:1088–92. https://pubmed.ncbi.nlm.nih.gov/34056990/.
   PubMed Web of Science ®Google Scholar
• Prete SD, De Luca V, Bua S, et al. The effect of substituted benzene-sulfonamides and clinically licensed drugs on the catalytic activity of CynT2, a carbonic anhydrase crucial for escherichia coli life cycle. Int J Mol Sci 2020;21:4175. https://www.mdpi.com/1422-0067/21/11/4175/htm.
   PubMed Web of Science ®Google Scholar
• Del Prete S, De Luca V, De Luca V, et al. Anion inhibition studies of the beta-carbonic anhydrase from Escherichia coli. Molecules 2020;25:2564. https://www.mdpi.com/1420-3049/25/11/2564/html.
   PubMed Web of Science ®Google Scholar
• Murray AB, Aggarwal M, Pinard M, et al. Structural mapping of anion inhibitors to β-carbonic anhydrase psCA3 from Pseudomonas aeruginosa. Chem Med Chem 2018;13:2024–9. https://pubmed.ncbi.nlm.nih.gov/30088334/.
   Google Scholar
• Pinard MA, Lotlikar SR, Boone CD, et al. Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa. Bioorg Med Chem 2015;23:4831–8. https://pubmed.ncbi.nlm.nih.gov/26068018/.
   PubMed Web of Science ®Google Scholar
• Angeli A, Pinteala M, Maier SS, et al. Inhibition of bacterial α-, β- and γ-class carbonic anhydrases with selenazoles incorporating benzenesulfonamide moieties. J Enzyme Inhib Med Chem 2019;34:244–9. https://pubmed.ncbi.nlm.nih.gov/30734601/.
   PubMed Web of Science ®Google Scholar
• More MS, Joshi PG, Mishra YK, et al. Metal complexes driven from Schiff bases and semicarbazones for biomedical and allied applications: a review. Mater Today Chem 2019;14:100195.
   PubMed Web of Science ®Google Scholar
• Oliveira AA, Oliveira APA, Franco LL, et al. 5-Nitroimidazole-derived Schiff bases and their copper(II) complexes exhibit potent antimicrobial activity against pathogenic anaerobic bacteria. BioMetals 2018;31:571–84. https://link.springer.com/article/10.1007/s10534-018-0106-6.
   PubMed Web of Science ®Google Scholar
• Bisceglie F, Bacci C, Vismarra A, et al. Antibacterial activity of metal complexes based on cinnamaldehyde thiosemicarbazone analogues. J Inorg Biochem 2020;203:110888.
   PubMed Web of Science ®Google Scholar
• Pham VH, Dung Phan TP, Phan DC, et al. Synthesis and bioactivity of thiosemicarbazones containing adamantane skeletons. Molecules 2020;25:324. https://www.mdpi.com/1420-3049/25/2/324/html.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang ZM, Li MX. Synthesis, characterization, and biological activity of cadmium (II) and antimony (III) complexes based on 2-acetylpyrazine thiosemicarbazones. Inorg Chim Acta 2022;530:120671.
   Web of Science ®Google Scholar
• Carradori S, Chimenti P, Fazzari M, et al. Antimicrobial activity, synergism and inhibition of germ tube formation by Crocus sativus-derived compounds against Candida spp. J Enzyme Inhib Med Chem 2016;31:189–93. 10.1080/14756366.2016.1180596.
   PubMed Web of Science ®Google Scholar
• Kaushal M, Lobana TS, Nim L, et al. Synthesis of 2-acetylpyridine-N-substituted thiosemicarbazonates of copper(II) with high antimicrobial activity against methicillin resistant S. aureus, K. pneumoniae 1 and C. albicans. New J Chem 2019;43:11727–42. https://pubs.rsc.org/en/content/articlehtml/2019/nj/c9nj01459d.
   Web of Science ®Google Scholar
• Ameryckx A, Pochet L, Wang G, et al. Pharmacomodulations of the benzoyl-thiosemicarbazide scaffold reveal antimicrobial agents targeting D-alanyl-D-alanine ligase in bacterio. Eur J Med Chem 2020; 200:112444. https://www.sciencedirect.com/science/article/pii/S0223523420304153?via%3Dihub.
   PubMed Web of Science ®Google Scholar
• Reis DC, Despaigne AAR, Da Silva JG, et al. Structural studies and investigation on the activity of imidazole-derived thiosemicarbazones and hydrazones against crop-related fungi. Molecules 2013;18:12645–62. https://www.mdpi.com/1420-3049/18/10/12645/html.
   PubMed Web of Science ®Google Scholar
• Hussein M, Hussein MB, Mohammed MM, et al. Synthesis, characterization, and antimicrobial activity of 4-imidazolecarboxaldehyde thiosemicarbazone and its Pt(II) and Pd(II) complexes. Eur J Chem 2021;12:56–9. https://www.eurjchem.com/index.php/eurjchem/article/view/2070.
   Google Scholar
• Bajaj K, Buchanan RM, Grapperhaus CA. Antifungal activity of thiosemicarbazones, bis(thiosemicarbazones), and their metal complexes. J Inorg Biochem 2021;225:111620.
   PubMed Web of Science ®Google Scholar
• Carradori S, Secci D, D’Ascenzio M, et al. Microwave and ultrasound-assisted synthesis of thiosemicarbazones and their corresponding (4,5-Substituted-thiazol-2-yl)hydrazines. J Heterocycl Chem 2014;51:1856–61. https://doi.org/10.1002/jhet.1856.
   Web of Science ®Google Scholar
• Mathew B, Baek SC, Parambi DGT, et al. Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors. Med Chem Comm 2018;9:1871–81. https://pubs.rsc.org/en/content/articlehtml/2018/md/c8md00399h.
   Google Scholar
• Mathew GE, Oh JM, Mohan K, et al. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease. J Biomol Struct Dyn 2021;39:4786–94. 10.1080/07391102.2020.1782266.
   PubMed Web of Science ®Google Scholar
• Jain J, Sanwaria AR, Gopal R, et al. Synthesis and characterisation of zinc and cadmium thiosemicarbazones: potential precursors for nano sized metal oxides/sulphides. Mater Res Innov 2022;26:36–43. 10.1080/14328917.2021.1880736.
   Google Scholar
• Yu X, Blanden A, Tsang AT, et al. Thiosemicarbazones functioning as zinc metallochaperones to reactivate mutant p53. Mol Pharmacol 2017;91:567–75.
   PubMed Web of Science ®Google Scholar
• Islam M, Khan A, Shehzad MT, et al. Synthesis and characterization of new thiosemicarbazones, as potent urease inhibitors: in vitro and in silico studies. Bioorg Chem 2019;87:155–62.
   PubMed Web of Science ®Google Scholar
• Noruzi EB, Shaabani B, Geremia S, et al. Synthesis, crystal structure, and biological activity of a multidentate Calix[4]arene ligand doubly functionalized by 2-Hydroxybenzeledene-thiosemicarbazone. Molecules 2020;25:370. https://www.mdpi.com/1420-3049/25/2/370/html.
   PubMed Web of Science ®Google Scholar
• Gaber A, Refat MS, Belal AAM, et al. New mononuclear and binuclear Cu(II), Co(II), Ni(II), and Zn(II) thiosemicarbazone complexes with potential biological activity: antimicrobial and molecular docking study. Molecules 2021;26:2288. https://www.mdpi.com/1420-3049/26/8/2288/html.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for Bacteria That Grow Aerobically. Approved Standard, 10th ed.; CLSI Document M07-A10; Wayne (PA): Clinical and Laboratory Standards Institute; 2015.
   Google Scholar
• Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeast, 4th ed.; CLSI Standard M27. Wayne (PA): Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antifungal susceptibility testing of yeasts, 1st ed.; CLSI Supplement M60. Wayne (PA): Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of Filamentous Fungi, 2nd ed.; CLSI Document M38-A2. Wayne (PA): Clinical and Laboratory Standards Institute; 2008.
   Google Scholar
• Angelini P, Matei F, Flores GA, et al. Metabolomic profiling, antioxidant and antimicrobial activity of Bidens pilosa. Processes 2021;9:903.
   Web of Science ®Google Scholar
• Ferrante C, Angelini P, Venanzoni R, et al. Antimicrobial, antioxidant, and antiproliferative effects of Coronilla minima: an unexplored botanical species. Antibiotics 2020;9:611. https://www.mdpi.com/2079-6382/9/9/611/html.
   Google Scholar
• Angelini P, Pellegrino RM, Tirillini B, et al. Metabolomic profiling and biological activities of Pleurotus columbinus Quél. Cultivated on different agri-food byproducts. Antibiotics 2021;10:1245. Available from: https://www.mdpi.com/2079-6382/10/10/1245/html.
   Google Scholar
• De Luca V, Petreni A, Carginale V, et al. Effect of amino acids and amines on the activity of the recombinant ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2021;36:1000–6.
   PubMed Web of Science ®Google Scholar
• Del Prete S, Bua S, Supuran CT, et al. Escherichia coliγ-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors. J Enzyme Inhib Med Chem 2020;35:1545–54. 10.1080/14756366.2020.1800670.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Morimoto K, et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem 2006;49:2117–26. 10.1021/jm0512600.
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Kohsaki T, et al. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. Bioorg Med Chem Lett 2007;17:3585–94.
   PubMed Web of Science ®Google Scholar
• Awale M, Reymond JL. Polypharmacology browser PPB2: target prediction combining nearest neighbors with machine learning. J Chem Inf Model 2019;59:10–7. https://pubmed.ncbi.nlm.nih.gov/30558418/.
   PubMed Web of Science ®Google Scholar
• Akdemir A, Angeli A, Göktaş F, et al. Novel 2-indolinones containing a sulfonamide moiety as selective inhibitors of candida β-carbonic anhydrase enzyme. J Enzyme Inhib Med Chem 2019;34:528–31. 10.1080/14756366.2018.1564045.
   PubMed Web of Science ®Google Scholar
• Kjxalifah RG. The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes b and c. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang L, Lv M, et al. AlzPlatform: an Alzheimer’s disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research. J Chem Inf Model 2014;54:1050–60. 10.1021/ci500004h.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717–3. https://www.nature.com/articles/srep42717.
   PubMed Web of Science ®Google Scholar